NewAge Industries Strengthens Leadership Team with Strategic Appointments

NewAge Industries, Inc. has taken significant steps to fortify its leadership team by appointing two industry veterans, Mark Thornton and Rick Chomik, to key positions. These appointments are poised to drive the company's strategic initiatives in the biopharma and industrial sectors, reflecting its commitment to innovation and global expansion.

Mark Thornton, MBA, joins the board with a wealth of experience in the biopharma industry, including his current role as President and CEO of VIO Biosciences. His expertise in global leadership and strategic vision is expected to play a pivotal role in guiding NewAge Industries through mergers and acquisitions, global expansion, and new product development. Thornton's appointment signals the company's ambition to scale new heights in the competitive biopharma landscape.

Rick Chomik, MS, steps into the newly created role of Vice President of Operations, bringing a strong background in engineering and operational management. His leadership is anticipated to enhance operational efficiency and foster innovation within the company. With previous roles including COO at the ALOE Group and positions at Stress Engineering Services, Chomik's operational acumen is set to streamline processes and drive growth.

Mary Marcus, CEO of NewAge Industries, Inc., has expressed optimism about the new appointments, emphasizing the value of Thornton and Chomik's extensive experience as the company embarks on its next phase of growth. These strategic hires underscore NewAge Industries' dedication to strengthening its foothold in the high purity pharmaceutical, biopharma, and industrial markets, promising to bring about significant advancements in the company's operations and strategic direction.